Literature DB >> 8109732

Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol.

C Nebot1, M Moutet, P Huet, J Z Xu, J C Yadan, J Chaudiere.   

Abstract

A new spectrophotometric assay of superoxide dismutase (SOD) activity is described. The assay is based on the SOD-mediated increase in the rate of autoxidation of 5,6,6a,11b-tetrahydro-3,9,10-trihydroxybenzo[c]fluorene (BXT-01050) in aqueous alkaline solution. This autoxidation yields a chromophore with a maximal absorbance wavelength of 525 nm. The optimized assay of SOD activity is performed at pH 8.8, 37 degrees C, in 50 mM air-saturated 2-amino-2-methyl-1,3- propanediol buffer containing 3 mM boric acid and 0.1 mM diethylenetriaminepentaacetic acid. The kinetic measurement of 525-nm absorbance is performed for 1 min upon addition of BXT-01050. BXT-01050 is stabilized in stock solution acidified at pH 1.5. The SOD activity is determined from the Vs/Vc ratio of the autoxidation rates measured in the presence (Vs) and in the absence (Vc) of sample. One SOD activity unit (U-525) has been defined as the activity that doubles the autoxidation background (Vs/Vc = 2). The equation that fits the standard curve is the same with all studied SODs. Another reagent, 1,4,6-trimethyl-2-vinylpyridinium trifluoromethanesulfonate, directly eliminates interference due to sample mercaptans such as glutathione by means of a very fast alkylation reaction. A fast and reproducible measurement of SOD activity requires only a single determination per sample. At pH 8.8, an optimal assay sensitivity is achieved without strongly affecting the activity of known SODs such as Cu/Zn-, Mn-, or Fe-SOD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8109732     DOI: 10.1006/abio.1993.1521

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  47 in total

1.  Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study.

Authors:  H Aly; H Elmahdy; M El-Dib; M Rowisha; M Awny; T El-Gohary; M Elbatch; M Hamisa; A-R El-Mashad
Journal:  J Perinatol       Date:  2014-11-13       Impact factor: 2.521

2.  Modification of cysteine 111 in Cu/Zn superoxide dismutase results in altered spectroscopic and biophysical properties.

Authors:  Mitchel D de Beus; Jinhyuk Chung; Wilfredo Colón
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

3.  Recombinant prion protein does not possess SOD-1 activity.

Authors:  Samantha Jones; Mark Batchelor; Daljit Bhelt; Anthony R Clarke; John Collinge; Graham S Jackson
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

4.  Cardiac mitochondrial damage and loss of ROS defense after burn injury: the beneficial effects of antioxidant therapy.

Authors:  Qun Zang; David L Maass; Jean White; Jureta W Horton
Journal:  J Appl Physiol (1985)       Date:  2006-08-24

5.  Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity.

Authors:  Y J Kang; Y Chen; A Yu; M Voss-McCowan; P N Epstein
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

6.  Antioxidant defense and oxidative damage vary widely among high-altitude residents.

Authors:  Allison J Janocha; Suzy A A Comhair; Buddha Basnyat; Maniraj Neupane; Amha Gebremedhin; Anam Khan; Kristin S Ricci; Renliang Zhang; Serpil C Erzurum; Cynthia M Beall
Journal:  Am J Hum Biol       Date:  2017-07-20       Impact factor: 1.937

7.  Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity.

Authors:  Suzy A A Comhair; Weiling Xu; Sudakshina Ghosh; Frederik B J M Thunnissen; Alexandru Almasan; William J Calhoun; Allison J Janocha; Lemin Zheng; Stanley L Hazen; Serpil C Erzurum
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Polyunsaturated fatty acid induces cardioprotection against ischemia-reperfusion through the inhibition of NF-kappaB and induction of Nrf2.

Authors:  Jorge G Farías; Catalina Carrasco-Pozo; Rodrigo Carrasco Loza; Néstor Sepúlveda; Pedro Álvarez; Mauricio Quezada; John Quiñones; Víctor Molina; Rodrigo L Castillo
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

9.  Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis.

Authors:  Heejeong Kim; Hwa-Young Son; Sarah M Bailey; Jaekwon Lee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-18       Impact factor: 4.052

10.  Ceruloplasmin and superoxide dismutase (SOD1) in heterozygotes for Wilson disease: A case control study.

Authors:  Gudlaug Tórsdóttir; Grétar Gudmundsson; Jakob Kristinsson; Jón Snaedal; Torkell Jóhannesson
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.